Eitr Biologics, Inc.
Eitr Biologics, Inc. received $3.2M in federal prime contract obligations in the 12 months ending Oct 5, 2026, down 44.8% from $5.8M the year before, and $39.6M since FY2022. Its largest customer is the Department of Health and Human Services.
See 3 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- HX49LZLY32G5
- CAGE code
- 99JH0
- Headquarters
- SAN Diego, CA
- Business size
- Small Business
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | $1.9M | $33.1M |
| Department of Defense | $1.3M | $6.5M |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| 3650 | Chemical and Pharmaceutical Products Manufacturing Machinery | $33.1M |
| AJ11 | General Science and Technology R&D services; General Science and technology; Basic Research | $4.7M |
| Q301 | Medical- Laboratory Testing | $1.8M |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| HT942626FE033 | Department of Defense NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY | $270K | Mar 31, 2027 |
| 75A50123C00060 | Department of Health and Human Services THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO… | $33.1M | Sep 30, 2027 |
| HT942526FE010 | Department of Defense NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY | $927K | Dec 31, 2027 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| HT942626FE055 | Department of Defense NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY | $100K | May 21, 2026 |
| HT942626FE033 | Department of Defense NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY | $270K | Mar 30, 2026 |
| HT942526FE010 | Department of Defense NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY | $927K | Jan 28, 2026 |
| HT942525F0221 | Department of Defense NOVEL NANOTHERAPEUTICS | $300K | May 19, 2025 |
| HT942524F0269 | Department of Defense NOVEL NANOTHERAPEUTICS | $1.1M | Aug 24, 2024 |
| HT942524F0127 | Department of Defense DEVELOP A NOVEL ODIN THERAPEUTIC MEDICAL COUNTERMEASURE CAPABLE OF PROTECTING AGAINST PNEUMONIC UNENCAPSULATED Y. PESTIS. | $500K | May 16, 2024 |
| HT942524P0015 | Department of Defense SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS | $530K | Dec 6, 2023 |
| 75A50123C00060 | Department of Health and Human Services THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO… | $9.6M | Sep 22, 2023 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.